GB1581367A - Secretin its production and purification - Google Patents
Secretin its production and purification Download PDFInfo
- Publication number
- GB1581367A GB1581367A GB29965/79A GB2996579A GB1581367A GB 1581367 A GB1581367 A GB 1581367A GB 29965/79 A GB29965/79 A GB 29965/79A GB 2996579 A GB2996579 A GB 2996579A GB 1581367 A GB1581367 A GB 1581367A
- Authority
- GB
- United Kingdom
- Prior art keywords
- leu
- arg
- ser
- secretin
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- OWMZNFCDEHGFEP-NFBCVYDUSA-N secretin human Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(N)=O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)C1=CC=CC=C1 OWMZNFCDEHGFEP-NFBCVYDUSA-N 0.000 title claims description 40
- 108010086019 Secretin Proteins 0.000 title claims description 38
- 102100037505 Secretin Human genes 0.000 title claims description 38
- 229960002101 secretin Drugs 0.000 title claims description 38
- 238000004519 manufacturing process Methods 0.000 title claims description 5
- 238000000746 purification Methods 0.000 title description 7
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 51
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 39
- 239000000203 mixture Substances 0.000 claims description 26
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 23
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 13
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 12
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 12
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 claims description 11
- 229960001305 cysteine hydrochloride Drugs 0.000 claims description 8
- AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridin-1-ium;chloride Chemical compound [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 claims description 8
- QIJRTFXNRTXDIP-UHFFFAOYSA-N (1-carboxy-2-sulfanylethyl)azanium;chloride;hydrate Chemical compound O.Cl.SCC(N)C(O)=O QIJRTFXNRTXDIP-UHFFFAOYSA-N 0.000 claims description 7
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 claims description 7
- 125000006239 protecting group Chemical group 0.000 claims description 6
- KPYXMALABCDPGN-HYOZMBHHSA-N (4s)-5-[[(2s)-6-amino-1-[[(2s,3s)-1-[[(2s)-1-[[(2s)-1-[[(2s)-1-[[(2s)-1-[[(2r)-1-[[2-[[2-[[(1s)-3-amino-1-carboxy-3-oxopropyl]amino]-2-oxoethyl]amino]-2-oxoethyl]amino]-1-oxo-3-sulfanylpropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]a Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)CNC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN)CC1=CC=C(O)C=C1 KPYXMALABCDPGN-HYOZMBHHSA-N 0.000 claims description 5
- HJBLUNHMOKFZQX-UHFFFAOYSA-N 3-hydroxy-1,2,3-benzotriazin-4-one Chemical compound C1=CC=C2C(=O)N(O)N=NC2=C1 HJBLUNHMOKFZQX-UHFFFAOYSA-N 0.000 claims description 5
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 5
- RHQDFWAXVIIEBN-UHFFFAOYSA-N Trifluoroethanol Chemical compound OCC(F)(F)F RHQDFWAXVIIEBN-UHFFFAOYSA-N 0.000 claims description 5
- 238000009903 catalytic hydrogenation reaction Methods 0.000 claims description 5
- 101800005164 Peptide V Proteins 0.000 claims description 4
- 239000003054 catalyst Substances 0.000 claims description 4
- 229960002433 cysteine Drugs 0.000 claims description 4
- 235000018417 cysteine Nutrition 0.000 claims description 4
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 4
- BBFCIBZLAVOLCF-UHFFFAOYSA-N pyridin-1-ium;bromide Chemical compound Br.C1=CC=NC=C1 BBFCIBZLAVOLCF-UHFFFAOYSA-N 0.000 claims description 4
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 claims description 3
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 3
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 3
- OWQPOVKKUWUEKE-UHFFFAOYSA-N 1,2,3-benzotriazine Chemical compound N1=NN=CC2=CC=CC=C21 OWQPOVKKUWUEKE-UHFFFAOYSA-N 0.000 claims description 2
- 101800001386 Peptide II Proteins 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims description 2
- 229910052763 palladium Inorganic materials 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 27
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- 239000000243 solution Substances 0.000 description 9
- 239000002904 solvent Substances 0.000 description 5
- 229940024606 amino acid Drugs 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 210000000496 pancreas Anatomy 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- XELZGAJCZANUQH-UHFFFAOYSA-N methyl 1-acetylthieno[3,2-c]pyrazole-5-carboxylate Chemical compound CC(=O)N1N=CC2=C1C=C(C(=O)OC)S2 XELZGAJCZANUQH-UHFFFAOYSA-N 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
- JWQZOTGHUDZFMU-WIDFLDSMSA-N 17034-35-4 Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(N)=O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)C1=CC=CC=C1 JWQZOTGHUDZFMU-WIDFLDSMSA-N 0.000 description 1
- HVCNXQOWACZAFN-UHFFFAOYSA-N 4-ethylmorpholine Chemical compound CCN1CCOCC1 HVCNXQOWACZAFN-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 101000623895 Bos taurus Mucin-15 Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- OLIFSFOFKGKIRH-WUJLRWPWSA-N Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CN OLIFSFOFKGKIRH-WUJLRWPWSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- XGDCYUQSFDQISZ-BQBZGAKWSA-N Leu-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(O)=O XGDCYUQSFDQISZ-BQBZGAKWSA-N 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- -1 cysteine hydrochloride Amino acid Chemical class 0.000 description 1
- 229940039227 diagnostic agent Drugs 0.000 description 1
- 239000000032 diagnostic agent Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 108010089804 glycyl-threonine Proteins 0.000 description 1
- ZRALSGWEFCBTJO-UHFFFAOYSA-N guanidine group Chemical group NC(=N)N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- 238000005897 peptide coupling reaction Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000011403 purification operation Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 230000036632 reaction speed Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/645—Secretins
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2615229A DE2615229C2 (de) | 1976-04-08 | 1976-04-08 | Verfahren zur Herstellung und Reinigung von Sekretin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1581367A true GB1581367A (en) | 1980-12-10 |
Family
ID=5974787
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB29965/79A Expired GB1581367A (en) | 1976-04-08 | 1977-04-07 | Secretin its production and purification |
| GB14824/77A Expired GB1581366A (en) | 1976-04-08 | 1977-04-07 | Secretin its purification |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB14824/77A Expired GB1581366A (en) | 1976-04-08 | 1977-04-07 | Secretin its purification |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4098779A (cg-RX-API-DMAC7.html) |
| JP (1) | JPS52125165A (cg-RX-API-DMAC7.html) |
| AT (1) | AT353991B (cg-RX-API-DMAC7.html) |
| BE (1) | BE853431A (cg-RX-API-DMAC7.html) |
| CA (1) | CA1090783A (cg-RX-API-DMAC7.html) |
| CH (1) | CH640510A5 (cg-RX-API-DMAC7.html) |
| DE (1) | DE2615229C2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK149045C (cg-RX-API-DMAC7.html) |
| FR (1) | FR2347337A1 (cg-RX-API-DMAC7.html) |
| GB (2) | GB1581367A (cg-RX-API-DMAC7.html) |
| IL (2) | IL51831A (cg-RX-API-DMAC7.html) |
| IT (1) | IT1083868B (cg-RX-API-DMAC7.html) |
| NL (1) | NL7703576A (cg-RX-API-DMAC7.html) |
| SE (1) | SE430060B (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2758578A1 (de) * | 1977-12-29 | 1979-07-05 | Hoechst Ag | Stabile sekretinzubereitung, verfahren zu ihrer herstellung und ihre verwendung |
| EP0021184B1 (de) * | 1979-06-13 | 1984-02-08 | Hoechst Aktiengesellschaft | Sekretinpräparate mit verstärkter und protrahierter Wirkung, Verfahren zu ihrer Herstellung sowie Dihydroxybenzoyl-L-tyrosin |
| JPS58134998A (ja) * | 1982-02-04 | 1983-08-11 | Wakunaga Yakuhin Kk | ２７−デスアミドセクレチンの製造法 |
| JPS57200343A (en) * | 1981-06-02 | 1982-12-08 | Wakunaga Yakuhin Kk | 27-desamidosecretin and its preparation |
| NZ205098A (en) * | 1982-08-06 | 1997-01-29 | Australian Wire Ind Pty | Wire, conductive coating on magnetic substrate: thickness determination |
| US6020310A (en) | 1997-05-19 | 2000-02-01 | Repligen Corporation | Method for assisting in differential diagnosis and treatment of autistic syndromes |
| US6197746B1 (en) | 1998-05-19 | 2001-03-06 | Repligen Corporation | Method of using secretin for treating autism |
-
1976
- 1976-04-08 DE DE2615229A patent/DE2615229C2/de not_active Expired
-
1977
- 1977-04-01 NL NL7703576A patent/NL7703576A/xx not_active Application Discontinuation
- 1977-04-05 IT IT22136/77A patent/IT1083868B/it active
- 1977-04-05 CH CH427777A patent/CH640510A5/de not_active IP Right Cessation
- 1977-04-06 US US05/785,181 patent/US4098779A/en not_active Expired - Lifetime
- 1977-04-06 DK DK154077A patent/DK149045C/da not_active IP Right Cessation
- 1977-04-06 IL IL51831A patent/IL51831A/xx unknown
- 1977-04-07 GB GB29965/79A patent/GB1581367A/en not_active Expired
- 1977-04-07 SE SE7704110A patent/SE430060B/xx not_active IP Right Cessation
- 1977-04-07 CA CA276,027A patent/CA1090783A/en not_active Expired
- 1977-04-07 AT AT244777A patent/AT353991B/de not_active IP Right Cessation
- 1977-04-07 GB GB14824/77A patent/GB1581366A/en not_active Expired
- 1977-04-08 BE BE176577A patent/BE853431A/xx not_active IP Right Cessation
- 1977-04-08 FR FR7710762A patent/FR2347337A1/fr active Granted
- 1977-04-08 JP JP3962777A patent/JPS52125165A/ja active Granted
-
1979
- 1979-11-02 IL IL58616A patent/IL58616A0/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK149045B (da) | 1985-12-30 |
| IT1083868B (it) | 1985-05-25 |
| CH640510A5 (de) | 1984-01-13 |
| DE2615229C2 (de) | 1984-05-24 |
| NL7703576A (nl) | 1977-10-11 |
| IL51831A (en) | 1980-05-30 |
| SE430060B (sv) | 1983-10-17 |
| IL58616A0 (en) | 1980-02-29 |
| GB1581366A (en) | 1980-12-10 |
| FR2347337A1 (fr) | 1977-11-04 |
| JPS6112920B2 (cg-RX-API-DMAC7.html) | 1986-04-10 |
| ATA244777A (de) | 1979-05-15 |
| DE2615229A1 (de) | 1977-12-29 |
| IL51831A0 (en) | 1977-06-30 |
| FR2347337B1 (cg-RX-API-DMAC7.html) | 1983-11-04 |
| DK154077A (da) | 1977-10-09 |
| DK149045C (da) | 1986-06-02 |
| JPS52125165A (en) | 1977-10-20 |
| SE7704110L (sv) | 1977-10-09 |
| AT353991B (de) | 1979-12-10 |
| BE853431A (fr) | 1977-10-10 |
| US4098779A (en) | 1978-07-04 |
| CA1090783A (en) | 1980-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3398960B1 (en) | Method for preparing semaglutide | |
| EP3505533B1 (en) | Synthesis method for low-racemization impurity liraglutide | |
| WO2014199397A2 (en) | Process for the preparation of liraglutide | |
| CN109180801A (zh) | 一种合成索玛鲁肽的方法 | |
| CA2024855C (en) | Process and intermediates for producing glucagon | |
| EP1179537B1 (en) | Solid phase peptide synthesis method | |
| US4439359A (en) | Cyclic octapeptide analogs of neurotensin | |
| US3917578A (en) | Process for producing somatostatin and intermediates | |
| US4098779A (en) | Process for the purification and manufacture of secretin | |
| CN115667318B (zh) | 一种索玛鲁肽衍生物及其制备方法和应用 | |
| CA1062249A (en) | Solid phase synthesis of acth | |
| CN113801233B (zh) | 一种索玛鲁肽的制备方法 | |
| Noda et al. | A facile method for preparation of t‐butyloxycarbonylamino acid p‐nitroanilides | |
| CA1059993A (en) | Polypeptides | |
| JP2563284B2 (ja) | 過塩素酸塩使用によるペプチドの製造方法 | |
| WO2021103458A1 (zh) | 一种地加瑞克的固相合成方法 | |
| WO2021007703A1 (en) | A method for preparing liraglutide via a solid phase peptide synthesis | |
| CN110922453A (zh) | 一种戈舍瑞林的合成方法 | |
| CN110922452A (zh) | 一种戈舍瑞林的合成方法 | |
| CA1340911C (en) | Antiherpes cyclic peptides | |
| EP0056274B1 (en) | Indole derivatives and a method for production of peptides | |
| US4055524A (en) | Synthesis of peptides | |
| JP2777193B2 (ja) | ペプチドの製造方法 | |
| WO2006105199A2 (en) | Compositions and methods for synthesis of peptide and related conjugate | |
| DK149632B (da) | Fremgangsmaade til fremstilling af sekretin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PCNP | Patent ceased through non-payment of renewal fee |